<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03460015</url>
  </required_header>
  <id_info>
    <org_study_id>9856</org_study_id>
    <nct_id>NCT03460015</nct_id>
  </id_info>
  <brief_title>Sevoflurane in Chronic Obstructive Pulmonary Disease Exacerbation</brief_title>
  <acronym>SEVOCOPD</acronym>
  <official_title>Evaluation of Sevoflurane in Chronic Obstructive Pulmonary Disease Exacerbation in Intensive Care Unit: A Comparative Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, open-label, single-center, study to investigate the effect of sevoflurane
      sedation compared to a propofol-controlled arm during COPD exacerbation requiring invasive
      mechanical ventilation in ICU.

      Primary outcome measure:

      Evolution of airway resistance before and after sevoflurane in COPD patients,

      Secondary outcomes measures:

      Respiratory mechanics (Maximum pressure, PEEPi and PEEPtot, trapped volume), Gas exchange by
      the help of blood gases, The heterogeneity of alveolar ventilation by electro-impedancemetry,
      Evolution of pulmonary inflammation, Trophicity and contractility of the diaphragm,
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 27, 2018</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of airway resistance before and after sevoflurane in COPD patients</measure>
    <time_frame>Hour 48</time_frame>
    <description>Total airway resistance will be measured using the ventilator by setting a 5s inspiratory pause and to measure the sum of (Pmax-P1)/Flow + (P1-Pplat)/Flow. The mechanical ventilation setting will be standardised during the study period and will be similar between the two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum pressure</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PEEPi</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PEEPtot</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trapped volume</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gas exchange by the help of blood gases</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heterogeneity of alveolar ventilation by electro-impedancemetry</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proinflammatory cytokines (IL1, IL6, TNFalpha) and sRAGE measurements in miniBroncho-Alveolar lavages</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thickness of the diaphragm measured by ultrasound</measure>
    <time_frame>Evolution between Hour 0 and Hour 48</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>COPD Exacerbation</condition>
  <condition>Invasive Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>Sevoflurane group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>During the first 30 minutes after randomization, patients will be treated with propofol (same dosage as the propofol group).
Once the AnaConDa® system is installed, sevoflurane administration will begin (propofol is stopped).</description>
    <arm_group_label>Sevoflurane group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>In the control group, sedation will be maintained with the above objective (RASS between -4 and -5, BIS between 40 and 60) until the patient is extubated.
In the sevoflurane group, propofol is administrated during the first 30 minutes after the randomization and when the AnaConDa® system is installed propofol is stopped.</description>
    <arm_group_label>Sevoflurane group</arm_group_label>
    <arm_group_label>Propofol group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria :

          -  COPD exacerbation

          -  Invasive mechanical ventilation and sedation for a planned duration of at least 24
             hours

          -  Consent

          -  Age ≥ 18 years

          -  Affiliation or beneficiary of a social security scheme

        Exclusion Criteria :

          -  Contraindication to the administration of sevoflurane (personal or family history of
             malignant hyperthermia, allergy or halogenated anesthetic accident, chronic myopathy,
             halogenated toxic hepatitis, uncontrolled intracranial hypertension, unexplained
             leukocytosis after anesthesia with a halogenated agent)

          -  Contraindication to the administration of propofol (known hypersensitivity to
             propofol, soy, peanut or any of the excipients of the emulsion, antecedent of Propofol
             Related Infusion Syndrome)

          -  Refusal of consent

          -  Guardianship

          -  Age &lt; 18 years

          -  Pregnant or lactating woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boris Jung, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Boris Jung, MD PhD</last_name>
    <phone>+33467337736</phone>
    <email>b-jung@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2018</study_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD exacerbation</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Airway Resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

